spaceISSN 1751-4983
Oncology News spacer
spacer
Contact Information
Patricia McDonnell, Publisher,
Oncology News,
McDonnell Mackie Publishing,
84 Camderry Road,
Dromore, Co Tyrone,
BT78 3AT, UK.
T: 0288 289 7023
E: info@oncologynews.biz
space
SEptember October 2010
   

powered by FreeFind
 
Editorial Board

Prof Denys Wheatley,
Director of BioMedES, & an Experimental Oncologist/Cell Biologist, Aberdeen.

Mr Patrick Bradley,
Otolaryngologist,
Head and Neck Surgeon,
Surgical Oncologist
University Hospital Nottingham.

Dr Richard J Ablin,
Research Professor of Immunobiology and Pathology
University of Arizona College of Medicine

space
Free Subscription
If you would like to receive a regular FREE copy of Oncology News, simply email your name, job title and address to subscribers@oncologynews.biz
space
Contributors
Do you have a topical article you would like to publish, or would you like to review books, journals, websites or conferences?
If you do, please contact enquiries@oncologynews.biz or call +44 (0) 288 289 7023.
 
space Editorial Board
 
Professor Denys Wheatley spacer

Professor Denys Wheatley is Editor of Oncology News, and is Director of BioMedES. In 1998, Denys became editor of Cell Biology International, and its reemergence and success led to a new online open access journal called Cancer Cell International. Latterly (May 2004), he started a second highly successful online open access journal called Theoretical Biology and Medical Modelling. He has strong research ties in Albany, Davis, Auckland, Valencia, Detroit, Budapest, St Petersburg, Heidelberg, Zürich and Hong Kong. He is eager to establish strong interaction with cancer and cell biology teams worldwide, and initiate programmes in the areas in which his expertise lies. His work in cancer research, other scientific fields, with IFCB, and in publishing and scientific communication has led to his receiving awards in recent years from Budapest (Professor of the Semmelweis Medical University), the Khwarizmi International Award for Science (Islamic Republic of Iran), a silver ‘Hippocrates’ award from the Medical University of Odessa (Ukraine), and a visiting chair of physiology/cancer research at Wayne State Medical School, Detroit, USA.

 

line

 

Mr Patrick J Bradley   Mr Patrick J Bradley is Associate Editor of Oncology News, and, a Head and Neck Oncologic Surgeon at the University Hospital, Nottingham. He completed his Otorhinolaryngology - Head and Neck Surgery residency in Liverpool. He is a member of numerous journals’ UK Editorial Boards; Journal of Laryngology and Otology, Oral Oncology, and International Journals: Laryngoscope, Head and Neck, Acta Otolaryngologica Scandinavia, as well as Section Editor of Head and Neck Oncology, and Current Opinions ORL-HNS. He has been the Gene Myers International Head and Neck Lecturer at the American Academy ORL-HNS in 2000. He recently completed an MBA (Health) at Nottingham University through an NHS Bursary over a five-year period. He is a member of the RCS London, Cancer Committee representing BAOHNS, and is Chairman of the BAOHNS Cancer Committee. He has been President of the British Association of Head and Neck Oncologists (2003 – 2005), and is currently President of the European Laryngological Society (2004 – 2006). He is a Founder Board Member of the European Head and Neck Society. He is the National Lead Clinician – Head and Neck Surgery for the English National Health Service (2003 – 2006).

 

line

Dr Richard J Ablin   Dr Richard J Ablin (Associate Editor), is Research Professor of Immunobiology and Pathology, University of Arizona College of Medicine and a Member of the Arizona Cancer Center, Tucson, Arizona. He received the First Award for scientific excellence from The Haakon Ragde Foundation for Advanced Cancer Studies. Dr Ablin discovered prostate-specific antigen (PSA) in 1970. A pioneer of cryosurgery and cryoimmunotherapy, he has extensive experience in cancer research.

 

line

Dr Tom Lynch   Dr Tom Lynch is Assistant Editor – Imaging, and is a Radiologist and Lead Nuclear Medicine Physician in the Northern Ireland Cancer Centre based at the Belfast City Hospital. Tom specialises in PET/CT scanning and nuclear medicine with a special interest in paediatric nuclear medicine. He also has an interest in radionuclide therapy, which is a rapidly developing area of interest in oncology using targeted therapy with beta emitters. Tom has a long history of involvement with undergraduate teaching and lectures regularly on PET/CT and Radionuclide therapy.

 

line

Dr Heidi Sowter   Dr Heidi Sowter is Assistant Editor – Web Review, and is a Lecturer in Forensic Science and Biology, at the Faculty of Education, Health and Science, University of Derby. Heidi became interested in oncology whilst working for a biotechnology company to automate cervical screening using labelled monoclonal antibodies raised from various cells along the CIN pathway. This interest took her to the Cambridge University Department of Obstetrics and Gynaecology at Addenbrookes Hospital, where she completed a PhD on Angiogenic Factors in Ovarian Cancer. Heidi continues to pursue her research interests in gynaecological and breast cancer.

 

line

Ms Kathleen Mais   Ms Kathleen Mais is Assistant Editor – Nursing, and is a Nurse Clinician in Head & Neck Oncology at Christie Hospital, Manchester. Kathleen qualified as a nurse in Newcastle-upon-Tyne. She worked as a ward sister on a female head and neck/ENT surgery ward, then as a sister in the Radiotherapy Outpatient Department at the Royal London Hospital. After completing a second Master’s degree in Clinical Nursing she took up her current position of Nurse Clinician. Kathleen is a nurseprescriber and runs a nurse-led chemotherapy clinic as well as continuing her work in clinical research.

 

line

Dr S Gokul   Dr S Gokul is Assistant Editor - Journal Reviews, and is a Consultant Medical Oncologist at The James Cook University Hospital, Middlesbrough, he undertook his oncology training at Newcastle upon-Tyne. His areas of interest are lung and gynaecological cancers.

 

line

Helen Evans   Helen Evans is a Journal Reviewer for Oncology News and works as a Senior Lecturer in Cancer Nursing at the Institute of Nursing and Midwifery, University of Brighton. Helen’s career in cancer nursing started on qualifying in 1987 and has spanned a range of roles from staff nurse to oncology service manager.

 

line

 

Marilena Loizidou   Marilena Loizidou is Assistant Editor – Colorectal, and is a nonclinical senior lecturer in the Department of Surgery, UCL. Previously, she held a research scientist post in the Department of Surgery, Southampton General Hospital. Marilena graduated in Biochemistry (Canada) and Pharmacology (Southampton) and completed a PhD in the biology of solid tumours (Southampton). Her research program focuses on aspects of colorectal cancer and liver metastases, from the basic underlying biology to new potential treatments and she has published extensively in the field. The current focus of research is the contribution of the peptide endothelin-1 to tumour growth and progression in the bowel. Additional research areas include breast and bladder cancer. Marilena has contributed to the design of an intercalated BSc and a Surgical MSc at UCL and lectures regularly.

 

line

Alan Cooper   Alan Cooper is Assistant Editor – Urology, and is lead scientist with the urology research group in Southampton University Hospitals and senior lecturer (albeit with virtually no lecturing burden) in the Department of Biomedical Sciences at Portsmouth University. His university education was in departments of zoology and immunology, but since joining the Southampton University Department of Surgery in 1974 has increasingly serviced the research interests of the Wessex urological fraternity, working for them exclusively over the last twelve years. His particular interest is live-cell imaging, exploited most extensively in the context of multidrug resistance in bladder cancer.

 

line

Michael Douek   Michael Douek is Assistant Editor – Breast, and is a Senior Lecturer and Consultant Surgeon at University College London Hospitals focusing on breast cancer surgery (including intra-operative radio - therapy, sentinel node biopsy and reconstruction) with a particular interest in pre-operative surgical planning using breast MRI. His translational research program evaluates novel imaging modalities to improve breast conserving surgery for cancer. He is a regular speaker at national and international conferences, published several papers in this area and made contributions in the health media. Michael graduated from the University of Dundee (Scotland) and trained in surgery in London, Oxford and Cambridge. He obtained his MD from the University of London in 2000. In 2003, he was awarded a prestigious Health Foundation Clinician Scientist grant by the UK Academy of Medical Sciences, fully funding his joint academic and clinical post in breast surgery.